Presentation Information
[P1-11-2]Episignature caused by loss of function of NSD2
○Tomoko Kawai1, Shiori Kinoshita1, Eriko Ohnishi1, Hiromi Kamura1, Miho Terao13, Tohru Sugawara14, Ohsuke Migita2, Masayo Kagami3, Tsuyoshi Isojima4, Yu Yamaguchi5, Keiko Wakui6, Hirofumi Ohashi7, Shimizu Kenji8, Seiji Mizuno9, Nobuhiko Okamoto10, Yoshimitsu Fukushima6, Fumio Takada11, Kenjiro Kosaki12, Shuji Takada13, Hidenori Akutsu14, Kazuhiko Nakabayashi1, Kenichiro Hata1,15 (1.Department of Maternal-Fetal Biology, National Center for Child Health and Development, Tokyo, Japan, 2.Department of Laboratory Medicine, St. Marianna University School of Medicine, Kanagawa, Japan, 3.Department of Molecular Endocrinology, National Center for Child Health and Development, Tokyo, Japan, 4.Department of Pediatrics, Teikyo University School of Medicine, Tokyo, Japan, 5.Gunma Childrens Medical Center, Gunma, Japan, 6.Department of Medical Genetics, Shinshu University School of Medicine, Matsumoto, Japan, 7.Division of Medical Genetics, Saitama Childrens Medical Center, Saitama, Japan, 8.Division of Clinical Genetics and Cytogenetics, Shizuoka Childrens Hospital, Shizuoka, Japan, 9.Department of Pediatrics, Central Hospital, Aichi Developmental Disability Center, Kasugai, Aichi, Japan, 10.Department of Medical Genetics, Osaka Women's and Childrens Hospital, Izumi, Japan, 11.Department of Medical Genetics and Genomics, Kitasato University Graduate School of Medical Sciences, Kanagawa, Japan, 12.Center for Medical Genetics, Keio University School of Medicine, Tokyo, Japan, 13.Department of Systems BioMedicine, National Center for Child Health and Development, Tokyo, Japan, 14.Department of Reproductive Medicine, National Center for Child Health and Development, Tokyo, Japan, 15.Department of Human Molecular Genetics, Gunma University Graduate School of Medicine, Gunma, Japan)